Expanded Application of the DOAC Score for Predicting Bleeding Events in All Anticoagulated Patients With Atrial Fibrillation ― An Integrated Analysis of 2 Prospective Japanese Registries-RAFFINE and SAKURA-AF ―
Background: Bleeding risk is a concern in patients with atrial fibrillation (AF) on oral anticoagulants (OACs). The DOAC score, a novel bleeding risk score, was developed for patients on direct OACs (DOACs), but its applicability to all anticoagulated patients remains unclear. The aim of this study was to validate the DOAC score in patients with AF who received any OACs.
Authors
- Shunsuke Kuroda (ORCID: https://orcid.org/0000-0002-7547-891X)
- Y N Nishizaki
- Kenichi Iijima (ORCID: https://orcid.org/0000-0002-0247-0204)
- Sakiko Miyazaki (ORCID: https://orcid.org/0000-0002-1979-8417)
- Hiroki Matsumoto (ORCID: https://orcid.org/0000-0001-5258-3883)
- Ryuta Watanabe
- Hidemori Hayashi
- Yasuo Okumura
- Tohru Minamino
- Katsumi Miyauchi
- Koichi Nagashima
- Hiroyuki Daida
Institutions
- Nihon University (JP)
- Juntendo University (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-05-11
- DOI
- https://doi.org/10.1253/circrep.cr-26-0061
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00